STAT News · Scour

STAT+: CMS, FDA team up to fast-track reimbursement for breakthrough devices

statnews.com·3w

STAT+: RFK Jr. backs off some MAHA issues

statnews.com·3w

STAT+: AMA calls for regulatory crackdown on chatbots, wellness AI

statnews.com·3w

Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift

statnews.com·3w

STAT+: Pharmalittle: We’re reading about cheap telehealth visits, pharma withholding meds in Europe, and more

statnews.com·3w

Across 7 hearings, RFK Jr. talks a new, more moderate MAHA

statnews.com·3w

STAT+: Can Erasca be biotech’s next big thing? We’ll see

statnews.com·3w

Opinion: Kennedy’s new silence on vaccines is political

statnews.com·3w

STAT+: Will bargain-basement telehealth visits help pharma drive drug scripts?

statnews.com·3w

STAT+: Publicly, Kennedy embraces a more moderate MAHA

statnews.com·3w

STAT+: Federal test of AI prior authorization is delaying care for seniors, report says

statnews.com·3w

Former tobacco executive joins CDC senior leadership, raising concerns over industry influence

statnews.com·3w

STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more

statnews.com·3w

Live: Robert F. Kennedy Jr. testifies before Senate HELP committee

statnews.com·3w

Increased calls to 988 hotline associated with a drop in suicides among young people, study finds

statnews.com·3w

STAT+: Gene therapy trial for deafness adds evidence to drug’s efficacy

statnews.com·3w

STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy

statnews.com·3w

STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more

statnews.com·3w

Moderna continues bird flu vax study, but limits work in the U.S.

statnews.com·3w

Opinion: NASA’s plans for living in space should prioritize immunology and infectious disease

statnews.com·3w

Log in to enable infinite scrolling